verapamil has been researched along with Spinal Cord Diseases in 2 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Spinal Cord Diseases: Pathologic conditions which feature SPINAL CORD damage or dysfunction, including disorders involving the meninges and perimeningeal spaces surrounding the spinal cord. Traumatic injuries, vascular diseases, infections, and inflammatory/autoimmune processes may affect the spinal cord.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the experiments on Wistar rats with pain syndrome of spinal origin (PSSO) caused by the generator of pathologically enhanced excitation (GPEE) in dorsal horns of the spinal cord lumbosacral segments, it was shown that the intravenous verapamil injection (1." | 7.68 | [Effects of verapamil on behavioral and microcirculatory disorders in pain syndrome of spinal etiology]. ( Gorizontova, MP; Igon'kina, SI; Kryzhanovskiĭ, GI; Speranskaia, TV, 1990) |
| "In the experiments on Wistar rats with pain syndrome of spinal origin (PSSO) caused by the generator of pathologically enhanced excitation (GPEE) in dorsal horns of the spinal cord lumbosacral segments, it was shown that the intravenous verapamil injection (1." | 3.68 | [Effects of verapamil on behavioral and microcirculatory disorders in pain syndrome of spinal etiology]. ( Gorizontova, MP; Igon'kina, SI; Kryzhanovskiĭ, GI; Speranskaia, TV, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kelley, RE | 1 |
| Berger, JR | 1 |
| Espey, M | 1 |
| Kelley, BP | 1 |
| Kryzhanovskiĭ, GI | 1 |
| Gorizontova, MP | 1 |
| Igon'kina, SI | 1 |
| Speranskaia, TV | 1 |
2 other studies available for verapamil and Spinal Cord Diseases
| Article | Year |
|---|---|
Presumptive human herpesvirus 6 myelopathy in an immunocompetent patient.
Topics: Adult; Amines; Anticonvulsants; Calcium Channel Blockers; Cyclohexanecarboxylic Acids; Female; Gabap | 2015 |
[Effects of verapamil on behavioral and microcirculatory disorders in pain syndrome of spinal etiology].
Topics: Animals; Behavior, Animal; Dipyrone; Male; Microcirculation; Pain; Rats; Rats, Inbred Strains; Spina | 1990 |